Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Xeljanz
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Xeljanz 10mg tablets
1001030ABBBABAC
|
Xeljanz | Tofacitinib | Musculoskeletal and Joint Diseases | No data available |
|
Xeljanz 11mg modified-release tablets
1001030ABBBACAD
|
Xeljanz | Tofacitinib | Musculoskeletal and Joint Diseases | No data available |
|
Xeljanz 5mg tablets
1001030ABBBAAAB
|
Xeljanz | Tofacitinib | Musculoskeletal and Joint Diseases | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.